Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021:2268:233-248.
doi: 10.1007/978-1-0716-1221-7_16.

NanoLuc-Based Methods to Measure β-Arrestin2 Recruitment to G Protein-Coupled Receptors

Affiliations

NanoLuc-Based Methods to Measure β-Arrestin2 Recruitment to G Protein-Coupled Receptors

Xiaoyuan Ma et al. Methods Mol Biol. 2021.

Abstract

Cytosolic β-arrestins are key regulators of G protein-coupled receptors (GPCRs) by sterically uncoupling G protein activation, facilitating receptor internalization, and/or acting as G protein-independent signaling scaffolds. The current awareness that GPCR ligands may display bias toward G protein signaling or β-arrestin recruitment makes β-arrestin recruitment assays important additions to the drug discovery toolbox. This chapter describes two NanoLuc-based methods to monitor β-arrestin2 recruitment to the human histamine H1 receptor by measuring bioluminescence resonance energy transfer and enzyme-fragment complementation in real-time on living cells with reasonable high throughput. In addition to the detection of agonism, both assay formats can be used to qualitatively evaluate the binding kinetics of antihistamines on the human histamine H1 receptor.

Keywords: Bioluminescence resonance energy transfer (BRET); Enzyme-fragment complementation (EFC); GPCR; Luciferase; Protein-protein interaction (PPI); β-Arrestin.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Insel PA, Sriram K, Gorr MW et al (2019) GPCRomics: an approach to discover GPCR drug targets. Trends Pharmacol Sci 40:378–387. https://doi.org/10.1016/j.tips.2019.04.001 - DOI - PubMed - PMC
    1. Hauser AS, Attwood MM, Rask-Andersen M et al (2017) Trends in GPCR drug discovery: new agents, targets and indications. Nat Rev Drug Discov 16:829–842. https://doi.org/10.1038/nrd.2017.178 - DOI - PubMed - PMC
    1. Gurevich VV, Gurevich EV (2019) GPCR signaling regulation: the role of GRKs and arrestins. Front Pharmacol 10:125. https://doi.org/10.3389/fphar.2019.00125 - DOI - PubMed - PMC
    1. Peterson YK, Luttrell LM (2017) The diverse roles of arrestin scaffolds in G protein-coupled receptor signaling. Pharmacol Rev 69:256–297. https://doi.org/10.1124/pr.116.013367 - DOI - PubMed - PMC
    1. Smith JS, Lefkowitz RJ, Rajagopal S (2018) Biased signalling: from simple switches to allosteric microprocessors. Nat Rev Drug Discov 17:243–260. https://doi.org/10.1038/nrd.2017.229 - DOI - PubMed - PMC

Publication types

MeSH terms

LinkOut - more resources